• Skip to main content
CQDM
  • About
    • Who We Are ?
    • Team
    • Governance
    • EDI
    • Contact us
  • Achievement
    • Success Story
    • Structuring Initiatives
    • Funded Projects
  • Funding R&D
    • Program Overview
    • SynergiQC
    • Quantum Leap
    • Partenar-IA
    • Call for Ideas in Radiopharmaceuticals
    • Past Programs
  • Members and Partners
    • Become a Member
    • Our members
    • Our Partners
  • News and Events
    • Our News
    • News from the industry
    • Our Events
  • Careers
    • Working at CQDM
    • Available Positions
  • fr Changer la langue pour du français.
  • en Current language: English.
  • About
    • Who We Are ?
    • Team
    • Governance
    • EDI
    • Contact us
  • Achievement
    • Success Story
    • Structuring Initiatives
    • Funded Projects
  • Funding R&D
    • Program Overview
    • SynergiQC
    • Quantum Leap
    • Partenar-IA
    • Call for Ideas in Radiopharmaceuticals
    • Past Programs
  • Members and Partners
    • Become a Member
    • Our members
    • Our Partners
  • News and Events
    • Our News
    • News from the industry
    • Our Events
  • Careers
    • Working at CQDM
    • Available Positions

Funded Projects

  1. CQDM
  2. Achievement
  3. Funded Projects
Biologie et therapies

Biological and therapeutic

Preclinical development of a Pseudomonas aeruginosa vaccine

Bioinformatique et intelligence artificielle

Bioinformatics and artificial intelligence

Intelligent digital pathology applied to the diagnosis of neuroendocrine tumors of the pancreas

Biologie et therapies

Biological and therapeutic

In-vivo CAR-T therapy for glioblastoma by novel non-viral gene editing system

Bioinformatique et intelligence artificielle

Bioinformatics and artificial intelligence

Elatus: Chronically implantable unit-scale microelectrode array neuromodulation technology 

Biologie et therapies

Biological and therapeutic

Designing synthetic extracellular matrices to support neurodegenerative disease modeling

Biologie et therapies

Biological and therapeutic

Novel biological agents in the treatment of amyotrophic lateral sclerosis based on progranulin/granulin structure

Bioinformatique et intelligence artificielle

Bioinformatics and artificial intelligence

Conditional oncology therapies and companion diagnostics: an AI-optimized approach for enhanced clinical success 

Biologie et therapies

Biological and therapeutic

Treating acute decompensation of urea cycle disorders by transient implantation of an Encapsulated Liver Tissue

Biologie et therapies

Biological and therapeutic

Develop and evaluate antisense oligonucleotide (ASO) delivery using Feldan Shuttle technology for the treatment of respiratory lung diseases 

CQDM
Contact us
LinkedIn Twitter

© 2025 CQDM. All rights reserved.

  • Terms of Use
  • Privacy Policy
  • Site Map
  • Gérer mes Cookies
Manage your preferences
To provide the best experiences, we use technologies such as cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Failure to consent or withdrawal of consent may adversely affect certain features and functions.
Functional Always active
Storage or technical access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of transmitting a communication over an electronic communications network.
Preferences
Storage or technical access is necessary for the legitimate purpose of storing preferences not requested by the subscriber or user.
Statistics
Storage or technical access used exclusively for statistical purposes. Technical storage or access which is used exclusively for anonymous statistical purposes. In the absence of a subpoena, voluntary compliance by your internet service provider or additional records from a third party, information stored or retrieved for this sole purpose cannot generally be used to identify you.
Marketing
Storage or technical access is necessary to create user profiles in order to send advertisements, or to track the user on a website or on several websites with similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
See your preferences
{title} {title} {title}